Thursday, April 25, 2024
Blogger Facebook Linkedin Pinterest Twitter

Tag: investigational anti-amyloid beta protofibril

Lecanemab

Alzheimer’s drug lecanemab slows cognitive decline in clinical trial

HTP Desk - 0
Eisai, a Japanese pharmaceutical company headquartered in Tokyo, and American multinational Biogen have released the results from their phase III clinical trial of lecanemab,...
Healthtekpak delivers daily news, updates, analysis, case studies and industry scoops related to the health industry.
Contact us: editor@ippgroup.in
Blogger Facebook Linkedin Pinterest Twitter
© 2020. All content (text and/or media) is intellectual property of IPP Catalog Publications Pvt. Ltd.

This function has been disabled for HealthTekPak.

error: Content is protected !!